Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4263)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2019 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pan HM, Lang WY, Yao LJ, Wang Y, Li XL. shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells via VEGF-C/PI3K/AKT signaling pathway. World J Gastrointest Oncol 2019; 11(8): 622-633 [PMID: 31435463 DOI: 10.4251/wjgo.v11.i8.622] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i8/622.htm |
| Number | Citing Articles |
| 1 |
Lanxin Jiang, Xiaomin Gong, Wangdi Liao, Nonghua Lv, Runwei Yan. Molecular targeted treatment and drug delivery system for gastric cancer. Journal of Cancer Research and Clinical Oncology 2021; 147(4): 973 doi: 10.1007/s00432-021-03520-x
|
| 2 |
Xiu-Feng Li, Xiu-Juan Zhang, Fu-Rong Hao, Xiao-Tong Dong, Guo-Dong Xu, Yun-Xiang Zhang. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer. Journal of International Medical Research 2024; 52(3) doi: 10.1177/03000605241234558
|
| 3 |
Hui‐Min Liu, Ying Zhou, He‐Xiang Chen, Jiang‐Wan Wu, Shi‐Kun Ji, Liang Shen, Shao‐Peng Wang, Hong‐Min Liu, Ying Liu, Xing‐Jie Dai, Yi‐Chao Zheng. LSD1 in drug discovery: From biological function to clinical application. Medicinal Research Reviews 2024; 44(2): 833 doi: 10.1002/med.22000
|
| 4 |
Yongtao Xu, Baoyi Fan, Yunlong Gao, Yifan Chen, Di Han, Jiarui Lu, Taigang Liu, Qinghe Gao, John Zenghui Zhang, Meiting Wang. Design Two Novel Tetrahydroquinoline Derivatives against Anticancer Target LSD1 with 3D-QSAR Model and Molecular Simulation. Molecules 2022; 27(23): 8358 doi: 10.3390/molecules27238358
|
| 5 |
Yan-Jia Guo, Jing-Ru Pang, Yu Zhang, Zhong-Rui Li, Xiao-Lin Zi, Hong-Min Liu, Ning Wang, Li-Juan Zhao, Ya Gao, Bo Wang, Piet Herdewijn, Cheng-Yun Jin, Ying Liu, Yi-Chao Zheng. Neddylation-dependent LSD1 destabilization inhibits the stemness and chemoresistance of gastric cancer. International Journal of Biological Macromolecules 2024; 254: 126801 doi: 10.1016/j.ijbiomac.2023.126801
|
| 6 |
Mohammad Malekan, Nikolas K. Haass, Ghasem Rahmatpour Rokni, Nasim Gholizadeh, Mohammad Ali Ebrahimzadeh, Armaghan Kazeminejad. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives. Life Sciences 2024; 345: 122563 doi: 10.1016/j.lfs.2024.122563
|
| 7 |
Zeinab Babaei, Mojtaba Panjehpour, Hadi Parsian, Mahmoud Aghaei. SAR131675 exhibits anticancer activity on human ovarian cancer cells through inhibition of VEGFR-3/ERK1/2/AKT signaling pathway. Cellular Signalling 2023; 111: 110856 doi: 10.1016/j.cellsig.2023.110856
|
| 8 |
Belay Sibuh, Sameer Quazi, Hrithika Panday, Ritika Parashar, Niraj Jha, Runjhun Mathur, Saurabh Jha, Pankaj Taneja, Abhimanyu Jha. The Emerging Role of Epigenetics in Metabolism and Endocrinology. Biology 2023; 12(2): 256 doi: 10.3390/biology12020256
|
| 9 |
Yang Liu, Ting-Yu Chen, Zhi-Yan Yang, Wei Fang, Qian Wu, Chao Zhang. Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02327-7
|
| 10 |
Pengcheng Liu, Fan Yang, Lizhi Zhang, Ying Hu, Bangjie Chen, Jianpeng Wang, Lei Su, Mingyue Wu, Wenjian Chen. Emerging role of different DNA methyltransferases in the pathogenesis of cancer. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.958146
|
| 11 |
Di Han, Jiarui Lu, Baoyi Fan, Wenfeng Lu, Yiwei Xue, Meiting Wang, Taigang Liu, Shaoli Cui, Qinghe Gao, Yingchao Duan, Yongtao Xu. Lysine-Specific Demethylase 1 Inhibitors: A Comprehensive Review Utilizing Computer-Aided Drug Design Technologies. Molecules 2024; 29(2): 550 doi: 10.3390/molecules29020550
|
| 12 |
Chao Yang, Dan Li, Shaohong Zang, Lei Zhang, Zhangfeng Zhong, Yingtang Zhou. Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.955218
|
| 13 |
Mehrdad Hashemi, Rezvaneh Aparviz, Marzie Beickzade, Mahshid Deldar Abad Paskeh, Simin Khorsand Kheirabad, Zeinab Khazaei Koohpar, Amir Moravej, Hossein Dehghani, Hamidreza Saebfar, Mohammad Arad Zandieh, Shokooh Salimimoghadam, Mohsen Rashidi, Afshin Taheriazam, Maliheh Entezari, Saeed Samarghandian. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery. Biomedicine & Pharmacotherapy 2023; 169: 115927 doi: 10.1016/j.biopha.2023.115927
|
| 14 |
Peizhi Ma, Gang Jia, Zhiyu Song. Monobenzone, a Novel and Potent KDM1A Inhibitor, Suppresses Migration of Gastric Cancer Cells. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.640949
|
| 15 |
Bin Huang, Yao Lu, Zhuona Ni, Jinhong Liu, Yanbin He, Honglin An, Feimin Ye, Jiayu Shen, Minghe Lin, Yong Chen, Jiumao Lin. ANRIL promotes the regulation of colorectal cancer on lymphatic endothelial cells via VEGF-C and is the key target for Pien Tze Huang to inhibit cancer metastasis. Cancer Gene Therapy 2023; 30(9): 1260 doi: 10.1038/s41417-023-00635-w
|
| 16 |
Huanshan He, Xiang Li, Jintao Li, Yong Ning, Jun Luo, Huaiping Shi. A novel regulatory sex-skewing method that inhibits testicular DPY30 expression to increase female rate of dairy goat offspring. Journal of Animal Science 2024; 102 doi: 10.1093/jas/skad422
|